Retension Pharmaceuticals (RTSN) shares were down more than 11% in Friday trading after the company began trading on Nasdaq.
The shares were trading at $10.64 after opening at $10 and reaching a high of $11.60.
The company priced its initial public offering at $12 per share, expecting to raise $45 million in gross proceeds. The offering is expected to close Tuesday, Retension said late Thursday.
Price: 10.64, Change: -1.37, Percent Change: -11.38
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.